Mvision AI Oy
About Mvision AI Oy
Mvision AI Oy, a Helsinki-based healthcare AI company founded in 2017, specializes in developing advanced AI-powered solutions to enhance the efficiency and impact of cancer care, particularly in radiation therapy. The company’s core offerings are cloud-based software services that automate and standardize critical steps in radiotherapy treatment planning.
Their flagship products include Contour+, an AI-powered auto-contouring software, and Dose+, an FDA 510(k) cleared solution for AI-powered dose prediction in personalized radiotherapy treatment planning. These tools, along with Guide for training and Verify for accuracy assessment, are designed to streamline workflows by significantly reducing manual effort in tasks like organ-at-risk (OAR) contouring, potentially by up to 95%. This automation aims to cut down treatment waiting times from weeks to days, facilitating same-day cancer treatment. Mvision AI’s solutions are clinically evaluated, integrate seamlessly with existing DICOM-compliant treatment planning systems, and have been utilized in treating over 190,000 cancer patients across more than 22 countries.
For physicians, Mvision AI’s technology offers a means to achieve greater consistency and standardization in radiotherapy planning, reduce inter-planner variability, and free up valuable clinical time for more complex tasks and patient-focused care. The company is committed to continuous innovation, developing new solutions to further accelerate treatment processes and build a globally scalable cloud-based platform for cancer care.
Focus Areas
Business Intelligence
| Key Investors | J12 Ventures, Voima Ventures, Icebreaker.VC, Nuard Ventures, Business Finland R&D |
| Partnerships | Baylor College of Medicine (research and development agreement), Philips (working on agreement for Contour+ Access™ with CT Simulators), Tecnosan (distribution partnership), Turku University Hospital, Docrates Cancer Center, Kuopio University Hospital, National Cancer Center Singapore |
| Technology | Cloud-based AI solutions, Deep learning models, DICOM-compliant integration, AI-powered auto-segmentation, Machine learning-based dose prediction |
| FDA Clearances | 3 cleared products (estimated) |
What Physicians Need to Know
For physicians, MVision AI's solutions offer significant advantages by drastically reducing manual workload and increasing efficiency in treatment planning, freeing up valuable time for patient-facing tasks and potentially shortening patient waiting times from weeks to days. The AI models, trained on international guidelines, ensure improved consistency and quality of treatment plans, leading to more standardized and accurate contours and dose predictions, thereby reducing inter-planner variability and errors. This enhanced clinical confidence is supported by clinically validated solutions that provide reliable starting points for planning and aid in informed decision-making. The comprehensive anatomical coverage across over 300 structures reduces the need for manual delineation across various cancer sites. Furthermore, the seamless integration into existing clinical workflows minimizes disruption, and adherence to GDPR and HIPAA standards ensures robust patient data security and privacy.
MVision AI's solutions, including Contour+ and Dose+, are designed for seamless integration with all major radiotherapy treatment planning systems (TPS) through standard DICOM protocols. They offer both cloud-based deployment, allowing for easy and fast updates of AI algorithms, and local solutions to address stricter data protection regulations.
What the Web Says
MVision AI Oy is a Helsinki-based company specializing in AI-driven auto-segmentation services for radiation therapy and cancer care. Their solutions aim to streamline treatment planning, automate manual tasks, and improve treatment quality, ultimately allowing patients to receive treatment faster. The company has received FDA 510(k) Clearance for its guideline-based segmentation solution in the US and has expanded its services to new countries outside the EU and US. MVision AI has been recognized for its rapid growth, ranking among the top ten in the Deloitte Technology Fast 50 Finland 2024. They offer a comprehensive suite of products, including Contour+, Guide, and Verify, which are designed to enhance contouring accuracy, standardize practices, and reduce treatment planning time.
Overall: PositiveStrengths
- Streamlines clinical workflow and reduces contouring time significantly.
- Enhances the quality and precision of radiation therapy.
- Provides reliable and consistent contours, improving treatment quality.
- Integrates seamlessly with existing clinical workflows and hospital systems.
- Offers a comprehensive solution with AI-powered auto-contouring, guideline training, and contour assessment tools.
- Strong commitment to transforming cancer care and expanding access to life-saving treatments.
Limitations
- One Reddit user mentioned that MVision AI might be struggling in the US market.
- Some general downsides of AI vision tools include the need for a lot of data and training, which can be time-consuming and expensive, and potential struggles with unusual conditions or lighting.
- One user on Reddit preferred other products like Limbus for accuracy and workflow.
Based on reviews from: Google Search, Reddit, Indeed.com, Capterra, G2
Last updated: 2026-07-18
Videos
News, demos, and interviews about Mvision AI Oy.
Videos load interactively. If none appear, search YouTube for Mvision AI Oy →
Press & Coverage
Frequently Asked Questions
Related Companies
e4health is a healthcare consulting and services company that provides innovative solutions to hospitals, health systems, outpatient providers, and physician practices. The company focuses on addressing data, quality, and revenue challenges within the healthcare ecosystem. Their services are designed to streamline health information data and workflows, optimize coding, quality, and clinical documentation integrity processes, and […]
PayZen is a healthcare fintech company that leverages AI and automation to address the growing challenge of healthcare affordability for patients and financial stability for providers. The platform offers personalized, interest-free payment plans, extending up to 60 months, tailored to each patient’s ability to pay. This approach aims to remove financial barriers to care, allowing […]
Healthcare Finance.AI is dedicated to optimizing healthcare revenue cycles through cutting-edge AI technologies. The company aims to improve financial outcomes for healthcare providers while supporting their commitment to quality care and efficiency. Their solutions are designed to enhance revenue cycle efficiency, reduce claim turnaround times, and improve patient billing accuracy. Their platform leverages advanced analytics […]
The American Academy of Family Physicians (AAFP) is one of the largest national medical organizations in the United States, representing over 130,000 family physicians, residents, and medical students. Founded in 1947, its core mission is to improve the health of patients, families, and communities by serving the needs of its members with professionalism and creativity. […]
Imperial College Business School, a faculty of Imperial College London, is a leading institution that integrates business education with science, engineering, medicine, and technology. For physicians and healthcare providers, the Business School offers specialized programs and research focused on the intersection of AI, digital transformation, and healthcare management. Their curriculum is designed to equip healthcare […]
Columbia University, through its online learning platform edX, offers a range of educational programs, including those focused on artificial intelligence and its applications in healthcare. While not a direct AI product company, Columbia University provides foundational and advanced courses that equip physicians and healthcare providers with the knowledge and skills to understand, evaluate, and potentially […]